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Biochemical, pharmacological and electrophysiological evidence implies the existence of tissue specific isoforms of the 
L-type VDCC. The a, and a, subunits of the skeletal muscle calcium channel have been previously cloned and their ammo 
acid sequence deduced. Here we report the isolation and sequencing of a partial cDNA that encodes a heart specific 
isoform of the a, subunit. The amino acid sequence deduced from this part cDNA clone shows 64.7% similarity with 
the skeletal muscle ar subunit. Northern analysis reveals 2 hybridizing bands, 8.5 and 13 kb, in contrast to one 6.5 kb 
band in the skeletal muscle. Selective inhibition of mRNA expression in Xenopus oocytes by complementary oligodeoxy- 
nucleotides derived from the heart clone provides further evidence that the cDNA corresponds to an essential component 
of the VDCC. These data further support the existence of tissue-specific soforrns of the L-type VDCC. 
CaZ+ channel, voltage-dependent; Dihydropyridine receptor; Ion channel; cDNA cloning 
1. INTRODUCTION 
Based upon electrophysiological and phar- 
macological data, at least 3 distinct isoforms of a 
VDCC have been postulated [l-3] and designated 
N-, T- and L-types [4]. The L-type VDCC is 
characterized by its sensitivity to a pharmaco- 
logically important group of drugs called calcium 
antagonists [5,6]. These drugs are widely used in 
the treatment of cardiovascular diseases such as 
coronary artery disease, supraventricular arrhyth- 
mia, and hypertension [7,8]. The skeletal muscle 
L-type VDCC has been extensively studied and its 
putative structure consists of 5 polypeptides, 
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designated ~1, W, p, y, and S [9,10]. The LYI 
subunit contains the calcium antagonist drug 
binding domains [9,11]; this subunit has frequently 
been called the ‘DHP receptor’. Electrophysiologi- 
cal and pharmacological data are consistent with 
the presence of tissue specific isoforms of the L- 
type VDCC, in skeletal muscle, brain, heart, and 
vascular smooth muscle. The cyi subunit from 
skeletal muscle has been cloned and sequenced 
[12,13]. Using molecular cloning and Northern 
analysis, we present further evidence in favor of 
the existence of a heart specific isoform of the CYI 
subunit of the VDCC. 
2. MATERIALS AND METHODS 
A hgtl0 library, made from cDNA size selected from 4.5 to 
8.0 kb, was obtained from Dr David McLennan (University of 
Toronto); lo6 plaques were screened with a 4.3 kb EcoRI/SacI 
fragment of the skeletal muscle (~1 clone [13] by standard 
screening techniques 1141. Filters were prehybridized in a solu- 
tion of 50% formamide, 5 x STE (1 x STE: 100 mM NaCl, 
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10 mM Tris-HC1, pH 8.0), 0.1070 SDS, 5 × Denhardt's solution, 
and 200 mg/ml denatured salmon sperm DNA. Hybridization 
was carried out in the same solution with the addition of 
106 dpm/ml radioactively labeled probe [15l. Final filter washes 
were done in 1 × SSC (150 mM NaCI, 10 mM sodium citrate, 
pH 7.0), 0.loT0 SDS and 0.1070 sodium pyrophosphate. 
Northern analysis was performed by methods previously 
described [14]. Total RNA was prepared by the procedure of
Chomczynski and Sacci [16] and poly(A ÷) RNA was isolated by 
oligo(dT) affinity chromatography [17]. Total or poly(A ÷) 
RNA was electrophoresed in enaturing formaldehyde agarose 
gels and transferred to Nytran membranes (Schleicher and 
Schuell) according to the manufacturer's protocol. Washing 
conditions are stated in the figure legends. 
Sequencing of the cDNA clones was carried out by the 
dideoxynucleotide chain termination method [18]. Sequenase 
(US Biochemical) nd T7 polymerase (Pharmacia) reagent kits 
were used in addition to the method escribed. Sequence om- 
parisons were performed by DNanalyze program [19]. 
Deoxyoligonucleotide probes were synthesized byour DNA 
Core Facility with an automated DNA synthesizer (Applied 
Biosystems). The techniques of preparation a d injection of 
oocytes, selective inhibition of RNA expression i oocytes 
(hybrid arrest of translation), and measurement of calcium cur- 
rents have been previously described [20]. 
3. RESULTS 
In order to isolate a cardiac specific isoform of 
the DHP receptor, a cardiac Agtl0 cDNA library 
was screened with a skeletal muscle DHP receptor 
probe (4.3 kb EcoRI/SacI fragment) which con- 
tained most of the coding region. One clone, 
3.4 kb in length (fig.I, HTDHP 1.0), was original- 
ly isolated and sequenced. A fragment of this clone 
closest to the 5' end (a 1.35 kb BgllI fragment) 
was then radioactively abeled and used to rescreen 
the library. Several additional clones were isolated, 
the longest of which was 4.6 kb in length (fig.l, 
HTDHP 2.0). Restriction mapping and partial se- 
quencing showed that the overlapping regions of 
this clone were identical to HTDHP 1.0, and it 
covered an additional 1.2 kb in the 5' direction. 
In order to confirm the functional identity of the 
cDNA clone, we used the approach of hybrid ar- 
rest of mRNA expression in Xenopus oocytes by 
complementary oligodeoxynucleotides [20]. To 
this end, 3 complementary oligonucleotides were 
synthesized; one of these (DHPRH-OI) is com- 
plementary to the putative $4 voltage sensor egion 
of Motif 4 (fig.2). Two others (DHPRH-O2 and 
-03) were derived from the C-terminal region of 
the partial heart cDNA clone. These oligonucleo- 
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Fig.1. Restriction maps of isolated rabbit heart clones. The 
clones are represented from the 5' end to the 3' end. 
tide probes were hybridized to total cellular RNA 
isolated from rabbit heart. Then, aliquots of the 
hybridization mixture were injected into oocytes 
and 48 h later the calcium currents were measured. 
As the data summarized in table 1 indicate, all 3 
probes significantly inhibited the Bay K 8644-sen- 
sitive currents elicited by the injection of heart 
RNA into oocytes. On the basis of Bay K 8644 sen- 
sitivity, this current is identified as being carried by 
the L-type VDCC [4]. DHPRH-O2 did not inhibit 
sodium current produced by injection of RNA 
from mouse brain (1507+_282 nA, control, 
1327 ___ 299 nA, DHPRH-O2 25#g/ml). 
The deduced amino acid sequence of HTDHP 
2.0 shows 64.7°/0 similarity with the skeletal muscle 
DHP receptor (fig.2). Much of the similarity lies in 
the area of the membrane spanning regions. The 
heart isoform shows 68.7°7o similarity in the region 
of the skeletal muscle C~l comprised of residues 
617-1385, while the remaining C-terminal se- 
quence shows only 56.3°7o similarity. It is also 
notable that the last 135 amino acid residues of the 
skeletal muscle c~1 are completely divergent from 
the heart isoform. Furthermore, the heart clone 
encodes a C-terminus of 73 additional amino 
acids. 
Within the membrane-associated domains, it is 
of interest hat the similarity is greatest in stretches 
proposed to be embedded in the membrane, while 
intracellular and extracellular loops are more 
variable. One especially variable region is the ex- 
tracellular loop between the $3 and $4 segments of 
Motif 4. The heart isoform has 8 fewer amino 
acids in this region and only 4 direct matches. The 
extracellular loop between $5 and $6 of Motif 3, 
where the epitope for a monoclonal antibody to 
the skeletal muscle isoform (mab IIF7 [13]) is 
located, also shows significant divergence, possibly 
explaining the lack of cross-reactivity of this an- 
tibody between skeletal muscle and heart (Camp- 
bell, K., personal communication). However, the 
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Fig.2. Deduced amino acid sequence of HTDHP 2.0 vs the skeletal muscle (~1. In this figure, the first row of amino acids represents 
the skeletal muscle LYE primary structure [12] and the second row represents the sequence deduced from HTDHP 2.0. In the third row, 
* represents direct matches between the sequences and A represents conservative changes. Boxed in areas are potential PKA 
phosphorylation sites, and dashes are potentiated N-linked glycosylation sites. Transmembrane segments and segments from which 
the oligonucleotides for the hybrid arrest experiments were derived are underlined. 
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Table 1 
The effect of DHPRH-oligonucleotide probes on the expression of heart L-type VDCC in Xenopus oocytes 
July 1989 
RNA and Currents (nA) % inhibition of 
treatment Bay K 8644-sensitive 
No Bay K 8644 With Bay K 8644 heart current with 
oligonucleotide 
Mean (n) SE ( +_ ) Mean (n) SE ( +_ ) probe 
None a - 8.00 (5) 3.00 - - - 
Rabbit heart b - 25.00 (5) 8.00 - 96.00 (6) 16.00 
Rabbit heart c
DHPRH-O1 
(25/~g/ml) - 4.00 (4) 3.00** - 10.00 (4) 2.00*** 
Rabbit heart c
DHPRH-O2 
(25/zg/ml) - 6.00 (5) 7.00** - 11.00 (5) 2.00*** 
Rabbit heart c
DHPRH-O3 
(25/~g/ml) - 6.00 (5) 3.00* - 19.00 (5) 1.00"** 
89 
88 
80 
a Oocytes were injected with 50 nl hybridization buffer heated to 65°C for 2 min, the 37°C for 3.5 h 
b Oocytes were injected with 50 nl rabbit heart RNA solution (7 mg/ml) treated as in 'a' 
c Oocytes were injected with 50 nl hybridization mixture treated as in 'a' 
* Significant, p < 0.05; ** significant, p < 0.025; *** significant, p < 0.0005. The experiments were performed with 
oocytes of one frog. Entries are mean values; number of cells tested are given in parentheses. Negative values correspond 
to inward currents. Total RNA from 8-day-old rabbit heart was prepared according to [25]. Oocytes, where indicated, 
were injected with 50 nl RNA solution (7 mg/ml). Hybridization with oligonucleotide probes was done as described in 
[20]. Total RNA concentration was 7 mg/ml in all hybridizations and each oligonucleotide probe was at 25/~g/ml. Bay 
K 8644 (1 ttM was previously shown to be ineffective in increasing the endogenous calcium current in oocytes injected 
with hybridization buffer alone [20]. Microinjection of oligonudeotide probes in hybridization buffer failed to elicit 
calcium currents ignificantly higher than those of noninjected oocytes [20]. Oligonucleotide probes: DHPRH-O~ (5' 
CGCGGCTCAG CAGCTTGACC AGGCGCATGA CCCGGAACAG GCGGAAGAAG G3') is a reverse complement 
of the HTDHP2.0 corresponding tothe putative $4 region in the Motif 4 and represents he region between amino acid 
residues 1234-1250. DHPRH-O2 (5' TGGACGAGTA GCTGCTGGGG GTGAAAGTGG AGTCCACCAG 
CTTCTCGTGG 3') is a reverse complement located between amino acid residues 1630-1647. DHPRH-O3 (5' 
GGAGCTGAGC TTCCATGCTG CCTCCTGTGC CCGGACGGCA GGAGACAAGG 3 ') is a reverse complement of
a stretch between amino acid residues 1677-1694. The numbering of amino acids corresponds tothat of fig.2. Statistical 
analysis was done by using a one-tailed t-test 
$4 segments,  which are proposed  to be the vol tage 
sensors in all vo l tage-dependent  cat ion channels 
c loned thus far [21,22], also conta in  posit ively 
charged arginines and lysines in every 3rd or 4th 
pos i t ion.  
The  d i f ferences in the amino  acid sequence 
result in a number  o f  changes in potent ia l  sites for  
prote in  kinase A (PKA)  phosphory la t ion .  F ive o f  
the proposed  sites in the skeletal muscle are absent 
in the heart  i so fo rm (serine residues 687, 1757, 
1772, and 1854, and threon ine  residue 1552) and 2 
are conserved (serine residues 1502 and 1575). The 
deduced structure o f  the part ia l  c lone shows 3 new 
potent ia l  PKA sites at serine residues that corre-  
spond to 1450, 1724 and 1804 of  the skeletal mus-  
cle sequence.  Two new potent ia l  extracel lu lar  
N-g lycosy lat ion  sites also appear  in the heart 
i so fo rm at residues cor respond ing  to 1295 and 
1344. 
Nor thern  blots made with heart po ly (A  ÷) RNA 
were hybr id ized with d i f ferent  segments o f  
HTDHP 2.0 cDNA (fig.3, lanes 1-3) .  Each  o f  the 
probes hybr id ized with two mRNA species, one at 
8.5 kb and another  at 13 kb. With  each o f  the 
probes ,  the 8.5 kb transcr ipt  appeared to prov ide 
the prominent  band,  however ,  the weaker  13 kb 
t ranscr ipt  is also detectable.  When heart  po ly(A ÷) 
RNA was hybr id ized with a skeletal muscle ce~ 
probe  (4.3 kb EcoRI/SacI f ragment)  2 weak 
hybr id izat ion  signals, at 6.5 kb and 8.5 kb (fig.3, 
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Fig.3. Northern blots of skeletal muscle and heart RNA. Rabbit 
heart poly(A+) RNA and skeletal muscle total RNA were 
fractionated on a formaldehyde-agarose g l and transferred to 
a Nytran filter. Lanes l-4 contain rabbit heart poly(A+) RNA 
(2 pg each) and lanes 56 contain rabbit skeletal muscle total 
RNA (10 fig each). The blots were probed with fragments of the 
heart and skeletal muscle cDNAs as follows: lane 1, 1.6 kb 
SmaI fragment of HTDHPl.0; lane 2 and 5, 1.3 kb EgflI 
fragment of HTDHPl.0; lane 3, 0.9 kb BgnI fragment of 
HTDHP2.0; lanes 4 and 6,4.3 kb EcoRI/SacI from the skeletal 
muscle (~1 cDNA. Lanes 1, 2, 3, 5 and 6 were washed in 0.1 x 
SSPE with 0.1% SDS at 55°C. Lane 4 was washed in 1 x SSPE, 
0.1% SDS at 55°C. The 4 kb band in lane 1 and the 1.8 kb band 
in lane 4 were not reproducible and probably represent 
artifacts. 
lane 4), were noted. In contrast, the 1.3 kb BgflI 
fragment of clone HTDHP 2.0 only weakly 
hybridized to a 6.5 kb transcript in skeletal muscle 
total RNA (fig.3, lane 5). When Northern blots 
made from skeletal muscle total RNA were 
hybridized with a skeletal muscle cyr probe, the 
prominent transcript was a 6.5 kb message as 
previously reported [ 12,131. 
4. DISCUSSION 
The hybrid arrest of mRNA expression in 
Xenopus oocytes presented here clearly show that 
oligonucleotides derived from the putative heart 
specific cDNA are highly effective in inhibiting the 
expression of L-type VDCC activity in oocytes. As 
expected, the oligonucleotide which is complemen- 
tary to the S4 region (DHPRH-Or) exhibited a high 
degree (89%) of inhibition; this region is highly 
conserved among various ion channels [22]. 
Similar inhibition of current expression by the 
other 2 probes, which are specific for the HTDHP 
2.0 cDNA verifies that this clone codes for a car- 
diac isoform of the VDCC al subunit. It is impor- 
tant to note that the oligonucleotide probes are 
probably specific to calcium channel, since an ex- 
pressed sodium channel was not inhibited. 
The deduced amino acid sequence of HTDHP 
2.0 shows striking similarity to the skeletal muscle 
DHP receptor, but significant differences were 
also identified. Very strong similarities are seen in 
the areas of the membrane spanning regions. This 
was expected, as other ion channels also show 
significant homology in these regions [21,22]. 
Differences between the heart and skeletal mus- 
cle sequences are most apparent in extracellular 
and intracellular loops and in the cytoplasmic car- 
boxy1 tail. Five of the potential PKA phosphoryla- 
tion sites in the skeletal muscle are absent from the 
heart sequence. Among these 5 sites is Ser 687, 
which has been shown to be rapidly phospho- 
rylated by PKA [23] and has been proposed to be 
the in vivo site of regulation by this kinase [24]. In 
the heart sequence, however, an Ala is substituted 
for Ser 687. There is also a substitution for skeletal 
muscle Ser 1617, a residue that was found to be 
phosphorylated slowly in vitro [24]. 
The considerable differences in the sequence be- 
tween S3 and S4 segments of Motif 4, as well as 
among other extracellular domains, may con- 
tribute to the differences in antigenicity between 
the lieart and skeletal muscle cyi subunits. An- 
tibodies raised to the LYE subunit from skeletal mus- 
cle show no cross-reactivity with other tissues 
(Campbell, K., personal communication). The dif- 
ferences in potential glycosylation sites in these 
segments may contribute to this as well. The dif- 
ferences in sequence when compared to other L- 
type channel isoforms, in aspects uch as structural 
domains, phosphorylation sites, and glycosylation 
sites, may lead us to the identification of domains 
which are important for drug binding and kinetics 
of channel activation and inactivation. 
Northern analysis also shows major differences 
between the skeletal muscle and heart isoforms. 
The larger sizes of the heart transcripts indicate 
that the 2 proteins may be produced by different 
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genes or by differential splicing of transcripts from 
the same gene. The former seems more probable, 
as the nucleotide sequences show differences scat- 
tered throughout the sequence rather than large 
blocks of similar and dissimilar regions (not 
shown). The sizes of the heart ranscripts also sug- 
gest hat the heart ~x subunit may be a larger pro- 
tein than that of skeletal muscle. We showed here 
that it is 73 amino acids longer at the C-terminus; 
it may also be significantly onger towards the N- 
terminus. Alternatively, the transcripts may con- 
tain unusually long untranslated regions, although 
the 3 '-untranslated sequence appears to be of nor- 
mal length. 
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